MEK INHIBITOR-ASSOCIATED RETINOPATHY
Clinical trials for MEK INHIBITOR-ASSOCIATED RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new MEK INHIBITOR-ASSOCIATED RETINOPATHY trials appear
Sign up with your email to follow new studies for MEK INHIBITOR-ASSOCIATED RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer Drugs' hidden cost: tracking vision damage in melanoma patients
Knowledge-focused CompletedThis study looked at how certain melanoma cancer drugs affect patients' eyes and vision. Researchers followed 30 adults taking BRAF/MEK inhibitor combinations to understand how often these drugs cause retinal changes called MEKAR. Participants received regular eye exams before, d…
Matched conditions: MEK INHIBITOR-ASSOCIATED RETINOPATHY
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Doctors map eye damage from powerful melanoma drugs
Knowledge-focused CompletedThis study aimed to understand a specific eye side effect that can occur when people with melanoma take a common type of targeted drug therapy (BRAF/MEK inhibitors). Researchers closely monitored 14 patients' eyes during and after their cancer treatment to see how the retina chan…
Matched conditions: MEK INHIBITOR-ASSOCIATED RETINOPATHY
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:54 UTC